Terms: = Leukemia AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Diagnosis
20 results:
1. Diagnostic Utility of GATA3 and ISL1 in Differentiating Neuroblastoma From Other Pediatric Malignant Small Round Blue Cell Tumors.
Mohanty SK; Diwaker P; Mishra SK; Jha S; Lobo A; Panda SP; Sharma S; Kumar M; Arora S; Mallik V; Jain D; Jain E; Chakrabarti I; Varshney J; Beg A; Dixit M; Baisakh MR; Naik S; Sahoo SK; Akgul M; Balzer BL; Amin MB; Parwani AV
Int J Surg Pathol; 2024 Apr; 32(2):294-303. PubMed ID: 37312579
[TBL] [Abstract] [Full Text] [Related]
2. Epigenetic analysis reveals significant differential expression of miR-378C and miR-128-2-5p in a cohort of relapsed pediatric B-acute lymphoblastic leukemia cases.
Bhatia P; Singh M; Singh A; Sharma P; Trehan A; Varma N
Int J Lab Hematol; 2021 Oct; 43(5):1016-1023. PubMed ID: 33538126
[TBL] [Abstract] [Full Text] [Related]
3. Systematic computational identification of prognostic cytogenetic markers in neuroblastoma.
Qin C; He X; Zhao Y; Tong CY; Zhu KY; Sun Y; Cheng C
BMC Med Genomics; 2019 Dec; 12(1):192. PubMed ID: 31831008
[TBL] [Abstract] [Full Text] [Related]
4. Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.
Georgantzi K; Sköldenberg EG; Stridsberg M; Kogner P; Jakobson Å; Janson ET; Christofferson RHB
Pediatr Hematol Oncol; 2018 Mar; 35(2):156-165. PubMed ID: 29737901
[TBL] [Abstract] [Full Text] [Related]
5. Mitochondrial Bcl-2 family dynamics define therapy response and resistance in neuroblastoma.
Goldsmith KC; Gross M; Peirce S; Luyindula D; Liu X; Vu A; Sliozberg M; Guo R; Zhao H; Reynolds CP; Hogarty MD
Cancer Res; 2012 May; 72(10):2565-77. PubMed ID: 22589275
[TBL] [Abstract] [Full Text] [Related]
6. Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project.
Moroz V; Machin D; Faldum A; Hero B; Iehara T; Mosseri V; Ladenstein R; De Bernardi B; Rubie H; Berthold F; Matthay KK; Monclair T; Ambros PF; Pearson AD; Cohn SL; London WB
Eur J Cancer; 2011 Mar; 47(4):561-71. PubMed ID: 21112770
[TBL] [Abstract] [Full Text] [Related]
7. [Neonatal tumors].
Costa C; Rocha G; Grilo M; Bianchi R; Sotto Mayor T; Monteiro J; Guimarães H
Acta Med Port; 2010; 23(3):405-12. PubMed ID: 20654259
[TBL] [Abstract] [Full Text] [Related]
8. Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastoma.
Ashton LJ; Murray JE; Haber M; Marshall GM; Ashley DM; Norris MD
Pharmacogenet Genomics; 2007 Sep; 17(9):709-17. PubMed ID: 17700360
[TBL] [Abstract] [Full Text] [Related]
9. The role of the multidrug resistance-associated protein 1 gene in neuroblastoma biology and clinical outcome.
Pajic M; Norris MD; Cohn SL; Haber M
Cancer Lett; 2005 Oct; 228(1-2):241-6. PubMed ID: 15979785
[TBL] [Abstract] [Full Text] [Related]
10. Significance of survivin mRNA expression in prognosis of neuroblastoma.
Ito R; Asami S; Motohashi S; Ootsuka S; Yamaguchi Y; Chin M; Shichino H; Yoshida Y; Nemoto N; Mugishima H; Suzuki T
Biol Pharm Bull; 2005 Apr; 28(4):565-8. PubMed ID: 15802787
[TBL] [Abstract] [Full Text] [Related]
11. Association between congenital cardiovascular malformations and neuroblastoma.
George RE; Lipshultz SE; Lipsitz SR; Colan SD; Diller L
J Pediatr; 2004 Apr; 144(4):444-8. PubMed ID: 15069390
[TBL] [Abstract] [Full Text] [Related]
12. Real-time analysis of tyrosine hydroxylase gene expression: a sensitive and semiquantitative marker for minimal residual disease detection of neuroblastoma.
Lambooy LH; Gidding CE; van den Heuvel LP; Hulsbergen-van de Kaa CA; Ligtenberg M; Bökkerink JP; De Abreu RA
Clin Cancer Res; 2003 Feb; 9(2):812-9. PubMed ID: 12576454
[TBL] [Abstract] [Full Text] [Related]
13. Neuroblastoma presenting as acute monoblastic leukemia.
Boyd JE; Parmley RT; Langevin AM; Saldívar VA
J Pediatr Hematol Oncol; 1996 May; 18(2):206-12. PubMed ID: 8846141
[TBL] [Abstract] [Full Text] [Related]
14. Pathology and immunology of acute leukemia.
Mirro J
Leukemia; 1992 Nov; 6 Suppl 4():13-5. PubMed ID: 1434816
[TBL] [Abstract] [Full Text] [Related]
15. Three neuroblastoma cell lines established from consecutive samples of one patient which show distinct morphologic features, mycn amplification, and surface marker expression.
Kees UR; Ford J; Dawson VM; Ranford PR; Armstrong JA
Cancer Genet Cytogenet; 1992 Apr; 59(2):119-27. PubMed ID: 1581878
[TBL] [Abstract] [Full Text] [Related]
16. Two malignant peripheral primitive neuroepithelial tumor cell lines established from consecutive samples of one patient: characterization and cytogenetic analysis.
Kees UR; Rudduck C; Ford J; Spagnolo D; Papadimitriou J; Willoughby ML; Garson OM
Genes Chromosomes Cancer; 1992 Apr; 4(3):195-204. PubMed ID: 1382559
[TBL] [Abstract] [Full Text] [Related]
17. Association of n-myc amplification with neuroblastoma: the Australian and New Zealand experience.
Telford DJ; Kavallaris M; White L; Norris MD; Brian MJ; Stewart BW
J Paediatr Child Health; 1992 Feb; 28(1):58-63. PubMed ID: 1554517
[TBL] [Abstract] [Full Text] [Related]
18. 5q- and t(2;11) in a patient with M2 acute non-lymphocytic leukemia. Case report.
Testoni N; Zaccaria A; Celso B; Tassinari A; Rosti G; Tura S
Haematologica; 1989; 74(6):595-9. PubMed ID: 2628243
[TBL] [Abstract] [Full Text] [Related]
19. The n-myc gene product in primary retinoblastomas.
Yokoyama T; Tsukahara T; Nakagawa C; Kikuchi T; Minoda K; Shimatake H
Cancer; 1989 Jun; 63(11):2134-8. PubMed ID: 2720564
[TBL] [Abstract] [Full Text] [Related]
20. [Detection of early stage cancer: pathological aspect with special reference to differential diagnosis].
Tanaka N
Gan No Rinsho; 1988 Aug; 34(10):1255-8. PubMed ID: 3172485
[TBL] [Abstract] [Full Text] [Related]
